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ER overload responseThe minute experience of disease progression happens in the cell. Whereas recent researches have
focused separately on disease, molecular mechanisms reveal the coincidence of pathways that provide
guided benefit to biomedicine. Interestingly, taken-for-granted mechanisms like endoplasmic reticulum
(ER) quality control or ion exchange and cell polarity indeed play major roles in epidemiologically rele-
vant problems like viral infection, tumorigenesis and other chronic disorders. The ER synthesizes proteins
destined for the nucleus and Golgi, as well as cell-surface receptors needed for cell-to-cell communica-
tion. This is therefore the target of viral infection in making the cell susceptible to receptor-mediated
invasion, and is usually affected in tumor cells to promote cell insensitivity. Any aberrations therefore,
such as protein unfolding, are acted upon by molecular chaperones and prevented from leaving the ER.
These proteins are essential for cell survival, and intuitively the ER must activate stress responses to
evade immediate cell dysfunction as the cell processes lag behind. This review will discuss mainly the
ER and its role in the pathogenesis and pathophysiology of epidemiologically-relevant diseases, as well
as updates on mechanisms related to the ER stress response.
 2017 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
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Disease begins and ends with the cell. Cellular homeostasis is of
vital importance, and has been shown to progress to senescence
and cell death should the protein machinery be consistently per-
turbed. However, the cell must not be thought of as passive. In
the event of cellular stress, genes that promote tolerance and
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such an extremity [1]. Since physiologic functions rely heavily on
homeostasis, it is not surprising that other aberrations such as
Ca2+ dysregulation, chronic inflammation, nutrient deficiency and
inappropriate extracellular ionic strength all contribute and possi-
bly induce stress in cells [2–4]. While there are manifold pathways
that describe the role of homeostasis in pathogenesis, the endeav-
our of unifying published concepts to profoundly describe disease
is of greater significance. In achieving a comprehensive under-
standing of a given disorder, it is important to recognize the
multi-factorial and multi-faceted nature of cell functions. For
instance, considering inflammation in the context of cell regulation
would lead to the role of T cells in immunological tolerance at ana-
tomic places where a pool of antigens are expected to be, such as in
the digestive tract [5–7]. Likewise, stress-induced inflammation
brought by cell necrosis even in the absence of a pathogen may
be realized as plausible [8,9]. To this end, the review will highlight
cross-talks between Ca2+ transport and the ER stress response,
which will be related to the pathogenesis and pathophysiology of
certain medical conditions.2. The ER stress response
The endoplasmic reticulum (ER) regulates the flow of macro-
molecules such as lipids, proteins and carbohydrates needed in
maintaining cell function. Accordingly, it is mandatory to maintain
homeostasis [10], and in cases where it is not, the organelle initi-
ates several pathways directed toward restoration, some of which
are not yet well-elucidated.
In usual cases, the effect of perturbation is aberrant protein
folding. Such mechanisms that the ER employs to regulate this
unwanted process are both preventive and modulatory in nature.
The ER recognizes peptides being newly synthesized through the
signal recognition particle (SRP) which causes an arrest in elonga-
tion and resumes being directed to the translocon in what is called
co-translational translocation [11,12]. Proper protein folding is
ensured by chaperones such as calreticulin and membrane-
bound calnexin as an orchestrated quality control point in the ER
[13]. Inhibitors targeting vital points in the glycoprotein biosynthe-
sis have been used to understand further the underlying mecha-
nisms for ER function, some of which are tunicamycin, an N-
glycosylation inhibitor; thapsigargin and 2,5-di-t-butyl-1,4-
benzohydroquinone (BHQ), which inhibit the sarco/endoplasmic
reticulum Ca2+-ATPase (SERCA), and castanospermine and 1-
deoxynojirimycin for glucosidase I and II inhibition, among others
[14]. Through these, it was found that persistently unfolded pro-
teins are targeted for either ER-associated (ERAD) or autophagic
degradation [15]. Intuitively, misfolding and degradation of pro-
teins must be addressed if the cell is to survive.3. Unfolded protein response (UPR)
The unfolded protein response is a well-known ER pathway
against challenges of stress. In physiologic conditions, the dsRNA-
activated protein kinase (PKR)-like ER kinase (PERK) is stabilized
by heat shock protein 90 (HSP90) and immunoglobulin heavy
chain binding protein (BIP); however, ER stress permits the release,
dimerization and autophosphorylation of PERK, which then phos-
phorylates the eukaryotic initiation factor 2 (eIF2) complex at the
Ser51 position leading to a cascade of events to attenuate protein
synthesis. Phosphorylated eIF2 has a manifold greater affinity for
GDP that would prevent re-initiation of translation due to lack of
eIF2B-mediated GTP exchange for reformation of the eIF2-GTP-
tRNAmet complex [16,17]. In this event, attenuation of mRNA trans-
lation occurs with a concomitant upregulation of genes translatinganti-stress proteins and amino acid transporters, such as the acti-
vating transcription factor 4 (ATF4). This protein interacts with
the ER and upregulates ER stress response genes associated with
both cell survival and apoptosis, with the matter of time in ques-
tion (Fig. 1).
In persistent accumulation of errors, ATF4 upregulates the tran-
scription of genes encoding C/EBP homologous protein (CHOP)/
GADD153 that activates ER-mediated apoptosis [18,19], probably
through repression of the B-cell lymphoma 2 (Bcl2) gene and sen-
sitization of cells to the persistent stress [3,20]. These are followed
by the upregulation of Bcl-2-like protein 11 (BIM) [21] that
together with BH3-only proteins preferentially activate Bcl-2-
associated X protein (BAX) to cause mitochondrial damage [22–
24]. As to how ATF4 executes such a time-sensitive response, the
PERK-dependent miR-211 inhibit the expression of CHOP until
apoptosis is deemed necessary [25]. Further, it is important to
acknowledge the short turnover of both CHOP and ATF4 – requir-
ing the presence of chronic ER stress to activate the apoptotic sig-
nals [26].
When ER stress is activated, BIP dissociates from the inositol-
requiring kinase 1 (IRE1) to permit IRE1 detection of protein mis-
folding [27,28], although BIP-independent detections have also
been proposed [29]. Having both endoribonuclease (ERN) and
serine-threonine kinase (STK) activities, the oligomerization at
the ER membrane and autophosphorylation at S724 of IRE1 allows
the ERN-mediated splicing and expression of X-box binding pro-
tein 1 (Xbp1) mRNA [10,30,31]. Xbp1 is a transcription factor that
together with nuclear factor Y (NF-Y) upregulate chaperone and
protein degradation genes for error fixation [32,33] while also
upregulating P58IPK that binds to the kinase domain of PERK.
Should the kinase domain of PERK be blocked, PERK activity would
decrease – permitting the expectation that the protein load of ER
would increase [34]. This downregulation of PERK activity has a
duality: in events that stress is relieved this would cease attenua-
tion of protein synthesis and homeostasis is achieved; however, in
persistent ER stress, the PERK-dependent miR-211 would cease to
attenuate CHOP expression which may eventually lead to further
stress and apoptosis [35,36] (Fig. 1). This activity of IRE1 is there-
fore essential in the later phase of the UPR [34,37]. What is of inter-
est to many diseases is the activity of IRE1a, which is present in
every cell, and constitutes the most conserved UPR cascade found
in eukaryotes – permitting in vivo studies to shed significant light
on the ER stress response [10,38].
Definitively, the kinase domain of IRE1 serves pro-apoptotic
functions in late-phase UPR. Its interactions with proteins lead to
the activation of procaspase-12 and the apoptosis signal regulating
kinase 1 (ASK1), eventually leading to c-Jun N-terminal kinase-
mediated cell death [39–41]. However, Lin, Walter and Yen pro-
posed that IRE1 also contributes directly to apoptosis by possible
downregulation of other mRNAs committed to ensuring survival
[10]. Nonetheless, consensus remains elusive.4. ER overload response (EOR)
Interestingly, EOR is one among others that bridge the gap
between the ER stress response and the regulation of Ca2+. For it
to occur, Ca2+ must be released from the ER followed by ROS pro-
duction, both of which lead to the activation of the nuclear factor
kappa-light-chain-enhancer of activated B-cells (NF-jB) [42]. It is
far less studied than the UPR, but its action can apply from acute
to chronic disease. In releasing Ca2+ stores from the ER lumen to
the cytosol, ROS production eventually leads to the activation of
NF-jB, which is a sequence-specific transcription factor that is a
key point in cell proliferation, inflammation and hence cell survival
[43,44] (Fig. 2A). Being a principal calcium storage and signalling
Fig. 1. The unfolded protein response (UPR) activates pathways dedicated to cell survival and cell death. In the presence of aberrations, HSP90 dissociates from PERK that
then phosphorylates eIF2a to attenuate protein translation. Likewise, it activates ATF4 that induces the transcription of CHOP – an apoptotic signal, and miR-211 that controls
it. miR-211 acts as a molecular switch, which downregulates during persistent stress, allowing CHOP to accumulate and mediate apoptosis. On the other hand, unfolded
proteins activate IRE1 that upon autophosphorylation induces splicing of Xbp1, which assists protein folding and degradation.
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Ca2+ homeostasis, which is why ionophores, glycosylation inhibi-
tors, toxins and unfolded proteins – all of which lead to ER lumen
Ca2+ depletion – trigger the ER stress response. During viral
transformation or glucose deprivation, transcription of glucose-
regulated protein (GRPs) is upregulated. These GRPs are
Ca2+-binding chaperone proteins, which by so binding perturbs
Ca2+ homeostasis and leads to the EOR [45,46]. Compared to the
UPR, the EOR seems to be more specialized in detecting Ca2+
perturbations. Recently, Wang et al. showed that TMCO1 encodes
for an ER transmembrane protein that acts as a Ca2+-load-
activated-Ca2+ channel (CLAC) in preventing luminal Ca2+ excess
(Fig. 2B), coupling with the Ca2+-release-activated-Ca2+ channel
(CRAC) to refill the ER lumen with Ca2+ [47]. Further, the EOR spe-
cializes in activating pathways leading to inflammation and cell
proliferation (via NF-jB) to promote cell survival, which is in stark
contrast to UPR. While the demarcation between UPR and EOR is
unclear, one must give way to the other in order to prevent redun-
dancy in mechanistic logic. We can infer that the UPR leads to a
defence state, while the EOR leads to an attack state.5. The ER stress response in Alzheimer’s and Parkinson’s
diseases
Ca2+ transport is an important process in all types of cells of an
organism, with no less emphasis on its role in cognitive function
and neurotransmission. The most widely accepted view of Alzhei-
mer’s disease (AD) is that it is a tauopathy – characterized by
hyperphosphorylated tau that is a grand hallmark of this disease
[48–50]. Another are Ab aggregates, originally deriving from
proteolysis of the amyloid precursor protein (APP) by b- and
c-secretases in preparation for carbohydrate modifications in theER. Since the precursor protein APP normally does not misfold in
the ER, it is not prevented from leaving the organelle. Katayama
et al. showed that by mutating the Presenilin-1 subunit of c-
secretase, IRE1 function in cell cultures was interfered [51]. Since
IRE1 is essential for the transcription of chaperones, this mutation
may partly explain why Ab continues to misfold in those whose c-
secretases have undergone mutation. Further, amyloidogenesis
seem to play a role in the UPR. By upregulating the expression of
APP, the expression of CHOP is enhanced, and since CHOP is vital
for apoptosis, then APP expression can lead to neuronal cell death
[52]. From here, it may be inferred that by reducing the capability
of cells to address protein misfolding and attenuating signals that
favour cell death, amyloidogenesis and b-amyloid aggregation
together lead to the death of neurons that are pathological hall-
marks of dementia. Indeed, by using c-secretase inhibitors, Taka-
hashi et al. showed that CHOP mRNA transcription decreased [53].
What is critical is that the continued presence of Ab aggregates
activate the UPR, and subsequent luminal Ca2+ release to activate
the EOR and other related pathways for cell survival also activates
GSK-3-b, which is a major tau kinase [54]. By so doing, an increase
in deposition of aggregates not only would lead to signals that
favour neuronal cell death but also to the hyperphosphorylation
of tau that causes the collapse of associated microtubules
(Fig. 3A) – leading to more unfolded proteins and eventually more
apoptosis [55]. Further, the activated UPR that leads to eIF2a phos-
phorylation to attenuate protein synthesis has also been shown to
increase the mRNA transcripts of BACE-1, which is a b-secretase
that leads to the production of more Ab [56]. Meanwhile, contin-
ued Ca2+ depletion leads to the EOR, which then activates NF-jB.
This explains in part why inflammation is a critical part of AD
pathophysiology and progression [57,58], since NF-jB activation
leads to cytokine production and subsequent recruitment of micro-
glial cells [59]. However, since processing of APP can happen in
Fig. 2. The ER Overload Response (EOR) as a response to homeostatic perturbations. (A) Normal processes in oxidative phosphorylation and cell-cell communication provide
reactive oxygen species (ROS) and Ca2+ at basal levels. In perturbations due to infection, toxins, or unfolded proteins, ROS production exceeds threshold, releasing calcium
stores into the cytosol and triggering the EOR to upregulate NF-jB, which leads to inflammation. (B) In reality, Ca2+ transport is a homeostatic process. In the absence of
perturbation, Ca2+ is released from the ER and refilled to serve cell signalling and signal transduction purposes. In the event of ROS overproduction, TMCO1, a recently
discovered Ca2+ ion channel in the ER, might be affected to perturb this equilibrium, leading to Ca2+ in the cytosol which when coupled with ROS above threshold will activate
the EOR.
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remains unclear where the main target for preventing aggregation
should be [59].
In Parkinson’s disease (PD), the trigger responses are said to be
more profound, especially since it involves two cell types – neu-
rons and myocytes. Being the most common neurodegenerative
disease second to AD, PD requires much attention, especially since
drugs designed to alleviate it often cause more harm long-term.
Genome-wide association studies (GWAS) for Japanese and Euro-
pean ancestries revealed the possible roles of leucine-rich repeat
kinase 2 (LRRK2) – a kinase implicated in loss of dopaminergic
(DA) neurons – and a-synuclein – proteins whose aggregates con-
stitute the Lewy bodies – in the pathogenesis and pathophysiology
of PD [60,61]. In addition, a certain protein termed Pael-R (Parkin-
associated endothelin receptor-like receptor), which is a G-protein
coupled receptor, has been shown to unfold spontaneously when
upregulated. This Pael-R is a substrate of Parkin, which is then
ubiquitinated and destined for proteasomal degradation. Hence,
mutations in the Parkin gene may lead to accumulation of Pael-R,
which may trigger the UPR. In fact, Pael-R-induced neuronal cell
death is observed in autosomal recessive juvenile parkinsonism,
or AR-JP [60,62].Studies have shown that a-synuclein affects Rab1, a protein
involved in trafficking components from the ER to the Golgi. Fur-
ther, a-synuclein directly interacts with nascent ATF6, effectively
preventing its association with COPII vesicles that generally trans-
fers proteins to the Golgi (Fig. 3B). These have certain implications:
(1) interfering with the Rab protein could lead to accumulation of
unfolded proteins in the ER, and (2) inhibition of ATF6 would gen-
erally stop the ERAD, triggering the cell to signal apoptosis [63].
What is interesting in PD is that it resembles the ‘minor-lethal’
requirements of the EOR. Mercado et al. found that by develop-
mental ablation of Xbp1, which is a transcription factor modulating
chaperone production, DA neurons were found to be more resis-
tant to 6-hydroxydopamine (6-OHDA) – a neurotoxin. This horme-
sis effect is striking, in that a little of something bad can actually
prime the cells to resist more of the worst to come [64]. Lastly, it
is important to realize that myocytes share the same stress
responses in PD. This is most clearly seen in PD therapy that
involves dopamine agonists or dopaminergic drugs such as
L-DOPA. Administration of these drugs mimics dopamine
signalling or produces dopamine, and since neither addresses DA
neurodegeneration, a typical PD patient would eventually need
a higher dose overtime. As the dosage of L-DOPA increases, an
Fig. 3. The ER stress response actively participates in the pathogenesis and pathophysiology of Alzheimer’s (AD) and Parkinson’s diseases (PD). (A) In AD, the production of
amyloid-b and its subsequent tendency to aggregate activates the ER stress response, which may either be the UPR, the EOR, or both. Perturbations deplete Ca2+ stores from
the ER lumen, which positively feedbacks the ER stress. In the process, GSK3-b is hyperactivated, hyperphosphorylating tau proteins leading to microtubule collapse. This loop
of protein unfolding persistently promotes inflammation, promoting death signals from the UPR that culminate in neurodegeneration. (B) In PD, aggregation of a-synuclein
activates the ER stress response, which when persistently activated will result to inflammation and neurodegeneration. Unfortunately, a-synuclein also associates with
nascent ATF6, preventing its delivery to the Golgi via COPII vesicles. Loss of mature ATF6 will lead to neurodegeneration.
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induced dyskinesia (LID). Depletion of luminal Ca2+ stores to favour
muscle contraction would then trigger ER stress. Triggering EOR, as
shown previously, results to the activation of NF-jB, and we
hypothesize that this explains in part why PD patients who expe-
rience LID or related dystonias also experience muscle inflamma-
tion and atrophy.
It may be tempting to think that ER stress is solely caused by
aberrations in the ER, but this is often not the case. Recently,
Celardo and colleagues showed that defective mitochondria may
also initiate the UPR. By inhibiting pink1 and parkin – a kinase
and an E3 ligase, respectively – in D. melanogaster, mitochondria
became dysfunctional, and these dysfunctional mitochondria led
to the UPR by forming mitofusin bridges with the ER. If mitofusin
contacts are reduced, even if the amount of defective mitochondria
remains unchanged, the PERK signalling pathway and hence the
UPR would subsequently be attenuated [65]. In this light, it is
important to realize that aberrations in organelles that interact
with the ER may also trigger the ER stress response, which points
out to the ER as being central to cell pathobiology.
6. The ER stress response in diabetes mellitus
Diabetes mellitus is a chronic disease divided into two types.
Type 1 (T1D) is an autoimmune disorder that leads to the destruc-tion of pancreatic b-cells and subsequent deficiency in insulin pro-
duction, while type 2 (T2D) is a complex mixture of metabolic
conditions leading to insulin resistance and eventual impaired
insulin secretion [66,67].
The islet of Langerhans comprise about 2% of the pancreas by
mass, and 60% of these are insulin-secreting. When glucose associ-
ates with b-cells after a full meal, insulin will only be produced and
secreted after ROS generation and stimulation of Ryanodine recep-
tors, followed by luminal Ca2+ release and subsequent increase in
intracellular Ca2+ stores. This response constitutes the glucose-
stimulated insulin secretion (GSIS) response, leading to insulin
release to relevant tissues such as muscle cells that are in need
of continuous energy source [68]. Therefore, any perturbations in
Ca2+ transport will prevent insulin secretion, and persisting high
blood glucose will lead to inflammation and destruction of the b-
cells. Profoundly, a hyperglycemic environment promotes the for-
mation of advanced glycation end products (AGEs), which is a
spontaneous chemical reaction forming Schiff-base Amadori prod-
ucts. Aside from the glycation of plasma proteins that induce apop-
tosis of b-cells, we hypothesize that membrane proteins of b-cells
also form AGEs, similar to what happens to red blood cells during
hyperglycemia. When these happen, AGEs can act as ligands to
RAGEs that are receptors constitutively expressed on immune cells
to detect microbes, or to RAGEs expressed on b-cell membranes
(Fig. 4). In fact, RAGE deficiency in mice has been shown to impair
Fig. 4. The ER stress response is partly responsible for pancreatic b-cell destruction. When aberrations in the Ca2+ ion channel or insulin insensitivity occur, insulin release
and action will not be possible. These result to persistent hyperglycemia, which forces b-cells to produce more insulin eventually leading to its wastage. The reactive oxygen
species (ROS) produced from these aberrations drives the EOR, which upregulates NF-jB to recruit immune cells to the b-cell location. Unfortunately, persistent high blood
glucose drives the Maillard reaction to form advanced glycation end products (AGEs) with either plasma proteins or possibly membrane proteins of b-cells. RAGE receptors on
b-cells will recognize glycated plasma proteins and induce apoptosis. The RAGE receptor in immune cells will also recognize the AGEs bound to pancreatic b-cells, leading to
their destruction. The persistent hyperglycemia and persistent recruitment of immune cells via the EOR perpetuates this cycle, contributing to the severity of diabetes
mellitus type 1.
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response. From here, it can be inferred that AGE formation can trig-
ger inflammation, which is characteristic of the autoimmune
response in T1D [69]. Indeed, the AGE-RAGE interactions in dia-
betes mellitus have been shown to lead to diabetic nephropathy
and retinopathy as well [70].
Due to genetic factors which are usually the cause of T1D, aber-
rations in translation or posttranslational modifications of proteins
lead to their unfolding, which may then trigger the ER stress
response [67]. When this couples with Ca2+ release and ROS pro-
duction prior to insulin release, the EOR response activates – lead-
ing to the activation of NF-jB that will subsequently lead to
inflammation. In T2D, insulin resistance either by mutations in
the insulin receptors or in the vesicular proteins transporting the
receptors to the cell surface lead to an increase in b-cell workload.
In this event, the persistent hyperglycemia promotes ROS genera-
tion and Ca2+ release, depleting the ER Ca2+ stores and triggering
ER stress. Eventually, UPR promotes attenuation of protein synthe-
sis, which would lead to a downregulation of insulin production
and eventually the depleted Ca2+ promoted by hyperglycemia
would cause b-cell exhaustion and ER-induced apoptosis [66,71].
Further, any mutations in the Ca2+ ion channels would lead to
accumulation of proteins and ROS in the b-cell, likewise triggering
the UPR or EOR. Indeed, both Ca2+ transport and the ER stress
response is critical in the pathogenesis and pathophysiology of dia-
betes types 1 and 2, and can therefore be targets for therapy.7. The ER stress response in viral infection and T-cell exhaustion
Quality control in the cell is a relatively taken-for-granted con-
cept in microbial infection. Normally, it is intuitive that cell senes-
cence or death depends upon exertion of microbial toxins or
hijacking the cell machinery as in viral infections. With quality
control in mind, this perception is shifted to recognize that cells
respond not only to detect and eliminate pathogen invasion butalso to limit damage and promote repair [72]. Of course, this ER
stress response forms a large barricade for intracellular pathogens
that aim to hijack the cell machinery for its survival. By attenuating
protein synthesis, for instance, viruses are confronted with a prob-
lem of how they can multiply. Further, activation of the EOR would
lead to cytokine production – such as IFN-c – that will inhibit viral
replication. Thus, the ER is a major barricade for infection, so much
so that viruses have evolved to tap into this defence mechanism
and stop it from protecting the host cell. In times of viral infection,
BIP associates with PERK, ATF6 and IRE-1 to attenuate protein syn-
thesis and mark ER-localized proteins for degradation. PERK will
phosphorylate eIF2a to stop translation; ATF6 will translocate to
the Golgi where upon cleavage would upregulate chaperone pro-
teins; IRE-1 would then facilitate formation of a mature Xbp-1,
and together would mark new protein for degradation [73].
Viruses have an arsenal of techniques to manipulate this
defence. For instance, hepatitis C virus stimulates the ATF6 path-
way, but inhibits that of IRE-1-Xbp (Fig. 5A). By so doing, chaper-
one proteins can help viral proteins to assemble, without being
marked for degradation [74]. On the other hand, the herpes sim-
plex virus encodes a protein whose c134.5 region is homologous
to the GADD34 protein. This protein is a component of the PERK
pathway that relieves translation attenuation. Since the herpes
protein is camouflaged to look like GADD34, it activates the PERK
pathway to inhibit CHOP via PERK-dependent miR-211, allowing
the cell to survive. Then, herpes blocks the phosphorylation of
eIF2a, allowing normal translation kinetics [75].
It only gets more striking in the case of HIV infection. During
infection, HIV induces ATF4 expression. Since ATF4 is involved in
a time-sensitive response for either cell survival or death, ATF4
can trigger HIV replication in the survival phase of the UPR, and
has been suggested to play a role in shifting viral latency to active
replication mediated by the Tat protein [76]. In terms of transla-
tion, Tat protein effectively competes with eIF2 for phosphoryla-
tion by and inhibits the activation of RNA-activated kinase (PKR),
leading to reactivation of translation processes [77]. Further, the
Fig. 5. Viruses have evolved mechanisms to evade the ER stress response. (A) In Hepatitis C (Hepa C) infection, the PERK pathway activates ATF6, which upregulates
chaperones assisting viral protein assembly. IRE1 is directly inhibited by Hepa C, preserving the viral proteins. Activation of NF-jB is partly responsible for liver inflammation
common to this infection. (B) In HIV infection, the synergistic action of both ATF4 and the HIV Tat protein activates viral replication and inhibits phosphorylation of eIF2a,
ending viral latency. HIV protein gp120 also upregulates pro-apoptotic proteins IRE-1, JNK and AP-1, tipping the balance between CHOP and miR-211 to instruct apoptosis
and to assist HIV progression to AIDS.
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apoptosis that can contribute to HIV progression to AIDS [78]
(Fig. 5B).
Meanwhile, IL-2 induces the splicing of Xbp-1 in CD8+ T-cells,
which in turn is critical for their differentiation into cytotoxic
T-cells [79]. Since CD4+ T-cells are the usual targets of HIV, aberra-
tions in these cells induce the ER stress response, which would lead
to translation attenuation. However, as many viruses have evolved
to hijack this defence, HIV continues to replicate and translate pro-
teins in the lymphocyte. This eventually exhausts the cell, leading
to its destruction. Continuous destruction of CD4+ T-cells deplete
MHC class II-restricted T-cells that subsequently depletes precur-
sors for T-helper cells (TH), which is critical for cell-mediated
immunity (CMI). As this happens, HIV also downregulates MHC
class I in infected CD4s, preventing detection by CD8+ T-cells. Fur-
ther, cytokine production is altered in such a way that stimulation
of CD8+ T-cells would lead to anergy [80]. In chronic HIV infection
without antiretrovirals, the high viral load is seen concomitantly
with a persistent elevation in CD8+ T-cell count which implies a
prolonged activity of these TCs. Actually, too much attention has
been placed on recovery of CD4+ T-cell count, while CD8 activity
has been largely neglected [81]. It must be realized that this points
out to a missing link in effective HIV therapy. Through some mech-
anism, HIV is able to activate CD8+ T-cells chronically. Too long an
activation (perhaps by cytokines) would deplete the Ca2+ storeswhich are released to activate the EOR for pro-inflammatory
responses and cytokine production, leading to T-cell exhaustion
and eventual cell death. Overtime, the number of naïve CD8+ T-
cells are depleted, and the TCs undergo anergy as the chronic HIV
infection persists. Lastly, it has been shown that Tat stimulates
an abnormal hyper-activation of human dendritic cells (DCs),
macrophages, as well as differentiation of CD8+ T-cells into TCs
[82,83]. In this way, HIV Tat is seen to promote inflammation
and exhausted CD8+ T-cells and innate immune cells while deplet-
ing CD4+ T-cell count and hence differentiated B-cell count in the
process.8. The ER stress response in tumorigenesis and cancer
Finally, it is noteworthy that the ER has a significant contribu-
tion in tumorigenesis and cancer, especially since the pathophysi-
ology of neoplasms include uncontrolled proliferation and
synthesis of proteins required to support this immense growth.
Intuitively, this growth must manipulate the ER. Activation of ER
stress has been shown to render tumor cells more resistant to
cellular insults due to cell survival promotion, while inhibiting
the signals that determine inflammation and cell apoptosis [84].
The most known of the genes involved is Bcl-2, which is the first
pro-survival gene discovered in the ER stress response [85]. In
Fig. 6. The ER stress response participates in tumorigenesis and cancer. In tumor progression, the immense metabolism of cells lead to overproduction of ROS and Ca2+
release, activating the EOR responsible for local inflammation in many cancers. Lowering glucose intake is thought to deprive these tumors of energy, leading to their
apoptosis. However, in the presence of lactic acidosis, tumors are able to shift their metabolism to oxidative phosphorylation, allowing survival and the persistent activation
of the UPR/EOR. In some cases of colon cancer, CHOP production is lost, leading to tumor survival. Meanwhile, mutations in IRE1 is associated with lung and breast
malignancies. Lastly, mutations in death signals of the Bcl-2 family of oncogenes promote survival, and is common to tumors resistant to chemotherapeutic agents.
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and increased transcription rates in malignancies such as non-
Hodgkin’s lymphoma and cancer of the lungs. This is made possible
by the loss of miRNAs that impose a threshold on the pro-survival
logic, as well as hypomethylations that promote permissiveness of
the Bcl-2 gene to transcription. This process, however, is not at all
simplistic. The Bcl-2 family of oncogenes are divided into two –
those that promote survival and those that promote death. Previ-
ously mentioned to promote survival are Bcl-2 and Bcl-XL, which
are induced during ER stress to promote survival. Meanwhile,
those that promote apoptosis are BAX and Bcl-2 homologous
antagonist killer (BAK), and either BAX or BAK can act as a suffi-
cient trigger for cell death when the cell can no longer address
its perturbations [85,86] (Fig. 6). Both stimulate the outer mem-
brane permeabilization of the mitochondria, which leads to cyto-
chrome c release and the activation of caspases. Meanwhile, the
dysfunctional mitochondria may produce mitofusin bridges that
will trigger the PERK pathway in a deadly combination ultimately
favoring apoptosis. Indeed, one of the reasons why some tumors
resist chemotherapy is because of an overexpression of anti-
apoptotic Bcl-2 oncogenes, and in a similar manner any mutations
in the apoptotic proteins BAX or BAK would lead to loss of death
signals that will allow cancer cells to resist treatment and continue
its proliferation [85] (Fig. 6).
Interestingly, the Bcl-2 family of oncogenes is not the sole
player in cancer. Previously, we have described that in times of
ER stress, IRE-1 is activated to promote differential splicing of nas-
cent Xbp-1 into mature Xbp-1. This pathway is actually upregu-
lated by cancer cells – especially in fibrosarcoma and lung
carcinoma – during hypoxic stress, whereas colon cancer cells
upregulate the PERK pathway to indirectly inhibit the transcription
of CHOP (Fig. 6). By so doing, chaperones will combat cell stress-
induced unfolding, which would render tumor cells resistant to
the consequences of immense metabolism. Further, in a hypo-
glycemic environment, tumors increase anaerobic glycolysis to
produce a lot of lactate that will decrease the pH of the cell. This
will lead to acidosis, and itself being a perturbation in normal pro-
ton concentrations would trigger the UPR to activate the Bcl-2 fam-
ily of oncogenes for survival [87–90]. Indeed, by regulating the
IRE1-Xbp-1 pathway, Rajapaksa and colleagues were able todemonstrate a decreased survival rate of breast cancer cells
in vitro [91]. Further, by removing lactate, tumor cells were not
able to survive a hypoglycemic environment (0.5 mM) – indicating
the role of UPR in tumor survival [92].9. Conclusion
Being a common denominator among all cell types, the ER gov-
erns mechanisms to ensure cell survival, integrity and function.
Therefore, it may also be a common target in diseases that seem
unrelated to one another – neurodegenerative disease, diabetes,
infection or cancer. Recent studies on the ER stress response shed
some light on a strong link between these cell-specific diseases,
and permitted guided benefit to biomedicine due to its broadly
applicable molecular pathways. Indeed, we are entering an era
where, in profound understanding of the basic science governing
various diseases, addressing the need to discover new drugs and
therapeutic approaches beyond one’s expertise is permitted. The
ER stress response is a set of molecular mechanisms that acts to
promote cell survival by upregulating chaperones to assist protein
folding, proteins to direct persistently unfolded proteins for degra-
dation, and transcription factors to bias transcription to certain
genes for survival, while generally attenuating translation of pro-
teins for normal cell function. Further, the ER activates NF-jB to
promote inflammation, in cases where immune cells are needed.
In some cases, the ER stress response fails, and leads to disease.
Still in others, viruses evade the response to effectively continue
viral replication. Indeed, the ER stress response is the organelle
that bridges the gap among these diseases.Conflict of interest
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